{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:13:53Z","timestamp":1790187233334,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hantaviruses are zoonotic negative-sense RNA viruses that cause haemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS), yet no approved antiviral therapies are available. To identify host-directed modulators of hantavirus infection we performed a drug repurposing screen using live Puumala virus (PUUV). We identified and validated 70 drugs with antiviral activity in A549 cells and primary human endothelial cells. Functional clustering confirmed the known infection-inhibitory effect of several groups of compounds, including inhibitors of heat shock proteins, mTOR pathway and nucleotide synthesis. Our screen also identified compounds yet unexplored as antivirals against Hantaviruses, such as certain antibiotics. Our dataset provides a systematic map of host pathways influencing PUUV infection and highlights candidate compounds and cellular processes that can modulate this process.<\/jats:p>","DOI":"10.1038\/s41598-026-57843-1","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T07:19:22Z","timestamp":1782371962000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A drug repurposing screen identifies antiviral compounds against Puumala Orthohantavirus"],"prefix":"10.1038","volume":"16","author":[{"given":"Wanda","family":"Christ","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8697-4740","authenticated-orcid":false,"given":"Bartlomiej","family":"Porebski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Fernandez-Capetillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Klingstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"57843_CR1","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.3390\/v15081705","volume":"15","author":"RX Chen","year":"2023","unstructured":"Chen, R. X. et al. Zoonotic Hantaviridae with Global Public Health Significance. Viruses 15, 1705 (2023).","journal-title":"Viruses"},{"key":"57843_CR2","doi-asserted-by":"publisher","first-page":"e371","DOI":"10.1016\/S1473-3099(23)00128-7","volume":"23","author":"PA Vial","year":"2023","unstructured":"Vial, P. A. et al. Hantavirus in humans: a review of clinical aspects and management. Lancet Infect. Dis. 23, e371\u2013e382 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"57843_CR3","doi-asserted-by":"publisher","first-page":"002077","DOI":"10.1099\/jgv.0.002077","volume":"106","author":"JH Kuhn","year":"2025","unstructured":"Kuhn, J. H. et al. Annual (2024) taxonomic update of RNA-directed RNA polymerase-encoding negative-sense RNA viruses (realm Riboviria: kingdom Orthornavirae: phylum Negarnaviricota). J. Gen. Virol. 106, 002077 (2025).","journal-title":"J. Gen. Virol."},{"key":"57843_CR4","first-page":"38","volume":"11","author":"JH Kuhn","year":"2023","unstructured":"Kuhn, J. H. & Schmaljohn, C. S. A Brief History of Bunyaviral Family Hantaviridae. Dis. (Basel Switz). 11, 38 (2023).","journal-title":"Dis. (Basel Switz)"},{"key":"57843_CR5","doi-asserted-by":"publisher","first-page":"584814","DOI":"10.3389\/fcimb.2020.584814","volume":"10","author":"Q Wang","year":"2021","unstructured":"Wang, Q. et al. Epidemic Trend and Molecular Evolution of HV Family in the Main Hantavirus Epidemic Areas From 2004 to 2016, in P.R. China. Front. Cell. Infect. Microbiol. 10, 584814 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"57843_CR6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.antiviral.2012.05.011","volume":"95","author":"A Papa","year":"2012","unstructured":"Papa, A. Dobrava-Belgrade virus: Phylogeny, epidemiology, disease. Antivir Res. 95, 104\u2013117 (2012).","journal-title":"Antivir Res."},{"key":"57843_CR7","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1017\/S0950268810000087","volume":"138","author":"P Makary","year":"2010","unstructured":"Makary, P. et al. Disease burden of Puumala virus infections, 1995\u20132008. Epidemiol. Infect. 138, 1484\u20131492 (2010).","journal-title":"Epidemiol. Infect."},{"key":"57843_CR8","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3390\/v11070610","volume":"11","author":"RL Brocato","year":"2019","unstructured":"Brocato, R. L. & Hooper, J. W. Progress on the Prevention and Treatment of Hantavirus Disease. Viruses 11, 610 (2019).","journal-title":"Viruses"},{"key":"57843_CR9","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s40506-020-00236-3","volume":"12","author":"K Dheerasekara","year":"2020","unstructured":"Dheerasekara, K., Sumathipala, S. & Muthugala, R. Hantavirus Infections\u2014Treatment and Prevention. Curr. Treat. Options Infect. Dis. 12, 410\u2013421 (2020).","journal-title":"Curr. Treat. Options Infect. Dis."},{"key":"57843_CR10","doi-asserted-by":"publisher","first-page":"1575112","DOI":"10.3389\/fimmu.2025.1575112","volume":"16","author":"A Tscherne","year":"2025","unstructured":"Tscherne, A., Guardado-Calvo, P., Clark, J. J., Krause, R. & Krammer, F. Puumala orthohantavirus: prevalence, biology, disease, animal models and recent advances in therapeutics development and structural biology. Front. Immunol. 16, 1575112 (2025).","journal-title":"Front. Immunol."},{"key":"57843_CR11","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3390\/v13040685","volume":"13","author":"J Mayor","year":"2021","unstructured":"Mayor, J., Torriani, G., Engler, O. & Rothenberger, S. Identification of Novel Antiviral Compounds Targeting Entry of Hantaviruses. Viruses 13, 685 (2021).","journal-title":"Viruses"},{"key":"57843_CR12","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.virs.2022.04.015","volume":"37","author":"X Wen","year":"2022","unstructured":"Wen, X. et al. Screening and identification of HTNVpv entry inhibitors with high-throughput pseudovirus-based chemiluminescence. Virol. Sin. 37, 531\u2013537 (2022).","journal-title":"Virol. Sin"},{"key":"57843_CR13","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1177\/2472555217699942","volume":"22","author":"A Roy","year":"2016","unstructured":"Roy, A. & Mir, M. A. Development of High-Throughput Screening Assay for Antihantaviral Therapeutics. SLAS Discov. 22, 767\u2013774 (2016).","journal-title":"SLAS Discov"},{"key":"57843_CR14","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1177\/2472555218766623","volume":"23","author":"T Buranda","year":"2018","unstructured":"Buranda, T. et al. A High-Throughput Flow Cytometry Screen Identifies Molecules That Inhibit Hantavirus Cell Entry. SLAS Discov. 23, 634\u2013645 (2018).","journal-title":"SLAS Discov"},{"key":"57843_CR15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1186\/s12859-021-04344-9","volume":"22","author":"DR Stirling","year":"2021","unstructured":"Stirling, D. R. et al. CellProfiler 4: improvements in speed, utility and usability. BMC Bioinform. 22, 433 (2021).","journal-title":"BMC Bioinform"},{"key":"57843_CR16","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1128\/JVI.77.1.481-488.2003","volume":"77","author":"WE Severson","year":"2003","unstructured":"Severson, W. E., Schmaljohn, C. S., Javadian, A. & Jonsson, C. B. Ribavirin Causes Error Catastrophe during Hantaan Virus Replication. J. Virol. 77, 481\u2013488 (2003).","journal-title":"J. Virol."},{"key":"57843_CR17","doi-asserted-by":"publisher","unstructured":"Bauherr, S. et al. Macropinocytosis and Clathrin-Dependent Endocytosis Play Pivotal Roles for the Infectious Entry of Puumala Virus. bioRxiv 694208 https:\/\/doi.org\/10.1101\/694208 (2019).","DOI":"10.1101\/694208"},{"key":"57843_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nm.4306","volume":"23","author":"SM Corsello","year":"2017","unstructured":"Corsello, S. M. et al. The Drug Repurposing Hub: a next-generation drug library and information resource. Nat. Med. 23, 405\u2013408 (2017).","journal-title":"Nat. Med."},{"key":"57843_CR19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/med.20104","volume":"28","author":"Q Shu","year":"2008","unstructured":"Shu, Q. & Nair, V. Inosine monophosphate dehydrogenase (IMPDH) as a target in drug discovery. Med. Res. Rev. 28, 219\u2013232 (2008).","journal-title":"Med. Res. Rev."},{"key":"57843_CR20","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1097\/TP.0000000000001777","volume":"102","author":"LJ Bowman","year":"2018","unstructured":"Bowman, L. J., Brueckner, A. J. & Doligalski, C. T. The Role of mTOR Inhibitors in the Management of Viral Infections: A Review of Current Literature. Transplantation 102, S50\u2013S59 (2018).","journal-title":"Transplantation"},{"key":"57843_CR21","doi-asserted-by":"publisher","first-page":"947789","DOI":"10.3389\/fimmu.2022.947789","volume":"13","author":"X Zhang","year":"2022","unstructured":"Zhang, X. & Yu, W. Heat shock proteins and viral infection. Front. Immunol. 13, 947789 (2022).","journal-title":"Front. Immunol."},{"key":"57843_CR22","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00284-024-03948-7","volume":"81","author":"A Bustos-Hamdan","year":"2024","unstructured":"Bustos-Hamdan, A., Bracho-Gallardo, J. I. & Hamdan-Partida, A. Bustos-Mart\u00ednez, J. Repositioning of Antibiotics in the Treatment of Viral Infections. Curr. Microbiol. 81, 427 (2024).","journal-title":"Curr. Microbiol."},{"key":"57843_CR23","doi-asserted-by":"publisher","first-page":"110302","DOI":"10.1016\/j.celrep.2022.110302","volume":"38","author":"L Yang","year":"2022","unstructured":"Yang, L. et al. Histone deacetylase 3 contributes to the antiviral innate immunity of macrophages by interacting with FOXK1 to regulate STAT1\/2 transcription. Cell. Rep. 38, 110302 (2022).","journal-title":"Cell. Rep."},{"key":"57843_CR24","doi-asserted-by":"publisher","first-page":"14742","DOI":"10.1073\/pnas.2433987100","volume":"100","author":"I Nusinzon","year":"2003","unstructured":"Nusinzon, I. & Horvath, C. M. Interferon-stimulated transcription and innate antiviral immunity require deacetylase activity and histone deacetylase 1. Proc. Natl. Acad. Sci. 100, 14742\u201314747 (2003).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"57843_CR25","doi-asserted-by":"publisher","first-page":"9140","DOI":"10.1128\/JVI.00717-10","volume":"84","author":"M Stoltz","year":"2010","unstructured":"Stoltz, M. & Klingstr\u00f6m, J. Alpha\/beta interferon (IFN-alpha\/beta)-independent induction of IFN-lambda1 (interleukin-29) in response to Hantaan virus infection. J. Virol. 84, 9140\u20139148 (2010).","journal-title":"J. Virol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57843-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57843-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57843-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T10:27:04Z","timestamp":1782383224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57843-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["57843"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-57843-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9268332\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"30 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19596"}}